San Francisco, April 26 (IANS) Former US President Donald Trump has decided not to join Twitter despite Tesla CEO Elon Musk buying it, saying "Twitter has become very boring".
Trump said that he will not return to Twitter and will instead use his own 'TRUTH Social' as the only social media platform.
"I am not going on Twitter, I am going to stay on TRUTH. I hope Elon makes improvements to it and he is a good man, but I am going to be staying on TRUTH," Trump was quoted as saying in a Fox News report late on Monday.
Trump said he will begin "TRUTHing" over the next week.
The former President announcement came moments after Musk won a takeover bid to take Twitter private for $44 billion at $54.20 a share.
"Twitter's become very boring. They've gotten rid of a lot of good voices on Twitter, a lot of their conservative voices," he said.
Trump was permanently suspended from Twitter, Facebook, Instagram, and Snapchat following the Capitol Hill riot on January 6, 2021.
"This is a platform for my voice. TRUTH is a platform for my voice and for my supporters," Trump said.
"But I want everybody to come over to TRUTH -- conservatives, liberals, whatever."
He did not comment if he was in contact with Musk.
"I hope that even my worst critics remain on Twitter, because that is what free speech means," Musk had tweeted.
The lawsuit takes aim at the leaders of the Hindu organization known as Bochasanwasi Akshar Purushottam Swaminarayan Sanstha, or BAPS, for human trafficking and exploitation of workers through low wages.
Tensions simmering in Jerusalem in recent days have taken deadly turn as militants in the Gaza Strip and Israel exchanged attacks, with at least 20 people killed, according to officials.
Many Indian Americans are wracked with guilt over emerging from more than a year of isolation as relatives overseas struggle to find vaccines, hospital beds and, fatefully, their breath.
Many of the 64 people affected either fainted or reported dizziness. Some got nauseous or vomited, and a few had racing hearts, chest pain or other symptoms.
In a statement Friday, the two pharmaceuticals said their submission to the European Medicines Agency is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective.
